首页> 外国专利> PREVENTION OF RECURRENCE OF URETHRAL STRICTURE AFTER A CONVENTIONAL TREATMENT

PREVENTION OF RECURRENCE OF URETHRAL STRICTURE AFTER A CONVENTIONAL TREATMENT

机译:常规治疗后预防尿道狭窄

摘要

Prevention of recurrence of urethral stricture after a conventional treatment. Composition applicable to the prevention of recurrence of urethral stricture after a conventional treatment, including a pharmaceutically effective amount of halofuginone. Urethral stricture, a common disease, appears secondary to urethritis, urethral infection, urethral inflammation, urethral instrumentation, urethral catheterization, urethral trauma, urethral surgery and all types of urethral lesions. Conventional treatments by internal urethrotomy, urethral dilation or surgical urethroplasty are available and can cure urethral stricture, but with a relatively high rate of recurrence of the stricture. Halofuginone can prevent the recurrence of urethral stricture after a conventional treatment via internal urethrotomy, urethral dilation or surgical urethroplasty.
机译:常规治疗后预防尿道狭窄复发。适用于常规治疗后预防尿道狭窄复发的组合物,包括药学上有效量的氟丁酮。尿道狭窄是一种常见疾病,继发于尿道炎,尿道感染,尿道炎症,尿道器械,尿道导管插入术,尿道创伤,尿道手术和所有类型的尿道病变。可以采用常规的内尿道切开术,尿道扩张术或外科尿道成形术治疗,并且可以治愈尿道狭窄,但狭窄复发率较高。在通过传统的内尿道切开术,尿道扩张术或手术性尿道成形术进行常规治疗后,氟丁酮可以预防尿道狭窄的复发。

著录项

  • 公开/公告号US2010305144A1

    专利类型

  • 公开/公告日2010-12-02

    原文格式PDF

  • 申请/专利权人 MEHDI JAIDANE;

    申请/专利号US20080739324

  • 发明设计人 MEHDI JAIDANE;

    申请日2008-10-23

  • 分类号A61K31/517;A61P9;

  • 国家 US

  • 入库时间 2022-08-21 18:11:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号